
Despite the significant success achieved in the treatment of multiple sclerosis zzso that allows to control the disease course, zzso have to use zzso in cases of progressive course or ineffectiveness of the zzso drugs zzso and zzso zzso Currently, zzso is one of the widely used zzso Thirty patients with zzso with zzso and zzso zzso receiving zzso were studied in the zzso zzso zzso Neurological status, frequency of zzso progression index were zzso Brain zzso was zzso Safety and zzso of zzso were assessed as zzso zzso of the study was on average 39 zzso The significant reduction of pathological process activity reflected in stopping zzso in zzso zzso was zzso The rate of disease progression was decreased significantly in zzso zzso The first results of this study revealed that zzso was well tolerated in the zzso and in the combination with zzso Because of remote risks of zzso all patients treated with zzso should be examined not only during the treatment but in the following zzso 

